Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Igenbio, Inc. Offers Metagenome Analysis Services for Clinical and Industrial Applications

Posted on: 17 Oct 16

Igenbio, Inc., a genomics and informatics solutions provider, has expanded its metagenomics and metatranscriptomics offerings. ERGO 2.0 is a cloud based “Software as a Service (SaaS) analytics platform” widely recognized as a leader in the genomics market. Igenbio, Inc now offers advanced services for metagenome and metatranscriptome analysis. ERGO provides quantitative biological population analysis, phylogenomics as well as gene expression analytics for meta RNA-Seq data. ERGO's content and analytics module is easy to use and powerful. Perform differential gene expression and clustering and generate high quality publication ready visualizations. “ERGO provides scientists meaningful results of metagenomes and metatranscriptome and eliminates the complexity of meta data management,” said Vinayak Kapatral, President and CEO of Igenbio, Inc. ERGO's metagenomics analytics module allows the exploration of phylogenetic hierarchies, metagenomic metabolic potential, and metatranscriptomics to discover expression dynamics between samples, treatments, and condition.

View source version on

Business Wire

Last updated on: 17/10/2016

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.